Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
Myomo appointed Mary-Katherine (Katie) McClure as Chief Commercial Officer effective October 12, 2026, succeeding Micah Mitchell, who departs after a transition period ending December 23, 2026. McClure spent 2018-2026 at Inspire Medical Systems, where company revenue grew from roughly $50 million to nearly $1 billion and her territories grew from $2 million to $150 million; she previously held senior sales roles at Medtronic, Tobii Dynavox and Johnson & Johnson. She received an inducement award of 275,000 time-based RSUs plus 225,000 performance RSUs at target (up to 337,500 shares) tied to 2029 financial metrics and Q4 2029 vs. Q4 2026 stock-price performance against peers.
Key figures
- Inducement rsu shares
- 275000
- Performance rsu max shares
- 337500
- Direct provider revenue share
- approximately 70% of annual revenues
- Performance rsu shares target
- 225000
- Inspire territory revenue growth
- $2 million to $150 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.